JOHN R STROEHLEIN to Stomach Neoplasms
This is a "connection" page, showing publications JOHN R STROEHLEIN has written about Stomach Neoplasms.
Connection Strength
0.244
-
Genetic and intermediate phenotypic susceptibility markers of gastric cancer in Hispanic Americans: a case-control study. Cancer. 2014 Oct 01; 120(19):3040-8.
Score: 0.201
-
Untreated gastric pseudolymphoma. Am J Dig Dis. 1977 May; 22(5):465-70.
Score: 0.015
-
Gastric heterotopia of the proximal esophagus: a report of four cases detected by endoscopy and review of literature. Am J Gastroenterol. 1986 Dec; 81(12):1162-6.
Score: 0.007
-
Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with upper gastrointestinal tumors. A preliminary report. Am J Clin Oncol. 1983 Aug; 6(4):473-6.
Score: 0.006
-
Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas. Cancer Treat Rep. 1982 Aug; 66(8):1613-7.
Score: 0.006
-
Rash, nephritis, hypertension, and haemolysis in patient on 5-fluorouracil, doxorubicin, and mitomycin-C. Lancet. 1980 Sep 06; 2(8193):534-5.
Score: 0.005
-
Gastric carcinoma in young adults. South Med J. 1979 Jun; 72(6):654-6.
Score: 0.004